Following the last workshop, Alison Rogers spoke with three leaders in the field to find out more about this growing alternative technology to kick off the 2026 series of From Lab to Life.

In this episode of From Lab to Life, we take you to a NAM symposium hosted by Bellberry and ASCEPT (Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists) held late in 2024.

Today Bellberry provides ethics reviews for more than 40% of the CTN clinical trials that take place in Australia and has re-invested $12 million into the research sector. 

In 2024 we celebrated 20 years of Bellberry with a focus on the difference we’ve made since we began. This was recognised with Bellberry winning the Telstra Best of Business award for Championing health late last year. 

In this episode of 'From Lab to Life' we hear from some of the people we work with about the impact of Bellberry.

Andrew is a former Chief Medical Officer of Victoria and has spent his career trying to get the best possible outcomes in public health through our state and federal governments. For someone focused on evidence based research, engaging in the political system can be a huge challenge.

In It’s All About the Participant we hear first-hand about what it’s like to be the participant and ask how could the experience be improved for others?

In Episode 9 of From Lab to Life we take a deep dive into the experience of those that have been on life-changing clinical trials.

Professor Emeritus Lloyd Sansom AO started his career as a pharmacist, going on to become Professor of Pharmacy as well as Head of the School of Pharmacy and Medical Sciences at the University of South Australia.   

In 2002 he was awarded an AO and in 2004 his contribution to the University was recognised with the naming of the Sansom Institute for Health Research.  

He was also Chair of the Australian Pharmaceutical Advisory Council from 1991-2000 and Chair for the Pharmaceutical Benefits Advisory Committee from 2001-2012. 

Recently Lloyd retired as a member of Bellberry’s Board and in this episode he gives us insight into his life, work and lessons learnt.  

In our latest episode of From Lab to Life we hear from three researchers and Bellberry HREC members who have a front row seat to the latest developments.

On the Horizon reveals that one of the biggest influences on medical innovation is the pandemic. Despite having a devastating effect across the globe it has forced immense change in medical research.

In Speaking From Experience we hear from Laureate Professor Ingrid Scheffer, Professor Doug Hilton, Emeritus Professor Ian Frazer, Professors Marnie Blewitt, Kim Jacobson and Di Yu about how they have navigated a successful path in the complex and demanding field of medical research.

What motivates an employee? And what’s the secret to having an engaged workforce?

In this episode of From Lab To Life, ‘All In A Day’s Work’, we meet the people that work every day for Bellberry.

In June 2023, Bellberry gathered representatives of regulators, reimbursement agencies, pharmaceutical companies and, most importantly, patient groups from around the globe to Adelaide, Australia, to examine the issue of accelerated access to potentially beneficial medicines. 

The challenge for the group was to agree on the principles to be considered when establishing processes to provide faster access to life-saving treatments. 

Gathering these experts in one place to focus on this difficult issue for three-and-a-half days was an achievement in itself. 

In this episode of From Lab To Life we meet some of the experts who attended this International Scientific Congress and hear their thoughts on this complex issue.